Rheumatoid Arthritis

pesquisadores obtiveram dados apontando um efeito pró-trombótico de Cox 2 como responsável pelo aumento das taxas de eventos cardiovasculares adversos nesses grupos. Outros dois estudos Farkouh e cols. publicaram uma análise de segurança no Therapeutic Arthritis Research and Gastrintestinal Event Trial (TARGET) (Farkouh, M.E., et al., 1999) onde não foi relacionado aumento de eventos cardiovasculares do inibidor da Cox 2 lumiracoxib comparado a naproxeno e ibuprofeno. Foi realizado o…

Ant-A , Ant-B e Ant-D podemos determinar o tipo sangüíneo de um individuo. Referências: Caderno. Lard LR, Visser H, Seyer I, Horst-Bruinsma IEV, Zwinderman AH, Breedveld FC et al. Early versus delayed treatment in patients with recent onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51. Relatório Fator Reumatóide Introdução: O fator reumatoide (FR), apesar…

Gastroenterol 2004;127:1076-1084. 47. Ip WK, Lau YL, Chan SY, Mok CC, Chan D, Tong KK et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arth Rheum2000;43:1679-1687. 48. Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheum 2001;28:728-734. 49. Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T,…

Gastroenterol 2004;127:1076-1084. 47. Ip WK, Lau YL, Chan SY, Mok CC, Chan D, Tong KK et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arth Rheum2000;43:1679-1687. 48. Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheum 2001;28:728-734. 49. Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K,…

1275-1279. 8. J.E.Balow. Choosing treatment for proliferative lupus nephritis. Arthritis and Rheumatism, 2002, August; 46 (8): 1981-3. 9. J.M.H.Moll. Drug Therapy (3): ”specific” drugs, in Management of rheumatic disorders, first edition, 1983. J.M.H.Moll, Chapman and Hall: Chapter 6, p.169-212. 10. A.Silman, J.Petrie, B.Hazleman and S.Evans. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.…

Rheumatology 2000 12(2):113-23. 8. Russel IJ, Neurohormonal aspects of fibromyalgia syndrome. Clin Rheum Dis N Am. 1989 15:149-68. 9. Russel IJ, Vaeroy H, Javors M e cols. Cerebrospinal fluid biogenic amines in fibrositis/fibromyalgia syndrome and rheumatoid arthritis. Arthitis Rheum 1992 35:550-56. 10. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995 345:99-103. 11. Provenza JR et al. Spect cerebral em…

Edition. Marc C. Hochberg, Allan J. Silman, Josef S. Smolen, Michael E. Weinblatt, Michael H Weisman. Mosby 2003 Philadelphia: pp 461-484. 3. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol 2008 27:67-76. 4. Hillmen P, Young N, Schubert J, Brodsky R, Socié G, Muus P, Röth A, Szer J, Elebute M, Nakamura R, Browne P, Risitano A, Hill A,…

br/wps/wcm/connect/5a1cb7804d01dc028a869a5 51355428f/BRATS_19.pdf?MOD=AJPERES>. Jornal brasileiro de patologia e medicina laboratorial, v. 47, n. 5, out. 2011. Disponível em: . Mayo Clinic. Disponível em: . National Rheumatoid Arthritis Society (NRAS). Disponível em: . MedicineNet.com. Disponível em: . Arthritis Foundation. Disponível em:

REFERÊNCIAS 1. 2. 3. 4. 5. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2(3):189– 202. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31(3):594–7. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358(9285):903–11. Rocha OMd, Batista AdAP, Maestá N, Burini RC, Laurindo IMM.…

Rheumatology 2000 12(2):113-23. 8. Russel IJ, Neurohormonal aspects of fibromyalgia syndrome. Clin Rheum Dis N Am. 1989 15:149-68. 9. Russel IJ, Vaeroy H, Javors M e cols. Cerebrospinal fluid biogenic amines in fibrositis/fibromyalgia syndrome and rheumatoid arthritis. Arthitis Rheum 1992 35:550-56. 10. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995 345:99-103. 11. Provenza JR et al. Spect cerebral em…